Last updated: August 15, 2023
Sponsor: Auburn University
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Placebo
Calcium Fructoborate
Clinical Study ID
NCT05438979
22-151 CFB
Ages 40-65 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Between 40-65 years of age;
- Self-reported or medically diagnosed knee joint pain for > 3 months (chronic);
- Diagnosis of osteoarthritis of the knee;
- No diagnosed psychiatric or neurological condition;
- Not taking antibiotics;
- Not taking any other joint health supplement
- Not taking prescription medications for OA or joint discomfort for the last 3 months
- No use of NSAIDS or other pain relievers for two (2) weeks prior to enrollment in thestudy and who are willing to make best efforts to refrain from use of same throughoutthe study
- Has reliable internet service;
- Some computer literacy;
- Has a smartphone; and
- Has a laptop, desktop computer, or iPad.
Exclusion
Exclusion Criteria:
- <40 or >65 years of age;
- Does not have osteoarthritis of the knee;
- Diabetes or other metabolic disorders;
- Inflammatory and/or infectious health conditions;
- Participants medically diagnosed with rheumatoid arthritis; 7) Participants withcardiovascular diseases; 8) Participants with liver and/or kidney problems; 9) Participantswho are pregnant; 10) Health conditions that would prevent the participant fromsuccessfully completing the study (i.e., motor control conditions such as Parkinson's;psychiatric conditions such as ADHD); 11) Use of antibiotics 1 month prior to theenrollment in the study; 12) Physician prescribed use of pharmaceutical medications for OAor joint discomfort within 3 months prior to enrollment in this study; 13) Any joint injuryin the 6-months prior to the enrollment in the clinical trial; 14) Unreliable or nointernet access/service; 15) Unable to use a smartphone or lacking the computer literacyneeded to complete the study 16) No laptop, desktop, or iPad that would allow for thecompletion of the study tasks.
Study Design
Total Participants: 300
Treatment Group(s): 2
Primary Treatment: Placebo
Phase:
Study Start date:
July 01, 2022
Estimated Completion Date:
December 31, 2024
Study Description
Connect with a study center
Auburn University
Auburn, Alabama 36849
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.